Cargando…
Cyclin‐dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget’s disease
Extramammary Paget’s disease (EMPD) is a rare adnexal neoplasm commonly seen in the genital areas among the senior population. The prognosis of advanced EMPD is not favorable; thus, the development of potential treatments has long been sought. Cyclin‐dependent kinase (CDK) 4/6 inhibitors such as abe...
Autores principales: | Kitamura, Shinya, Yanagi, Teruki, Maeda, Takuya, Ujiie, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819308/ https://www.ncbi.nlm.nih.gov/pubmed/34866279 http://dx.doi.org/10.1111/cas.15234 |
Ejemplares similares
-
HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
por: Tokuchi, Keiko, et al.
Publicado: (2022) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma
por: Maeda, Takuya, et al.
Publicado: (2023) -
Extramammary Perianal Paget's Disease
por: Al Hallak, M.N., et al.
Publicado: (2009) -
Mammary and extramammary Paget's disease()
por: Lopes, Lauro Lourival, et al.
Publicado: (2015)